DoW Spinal Cord Injury, Clinical Translation Research Award

Key facts

Copied from the official Grants.gov record. Last verified October 29, 2026.

Program name

DoW Spinal Cord Injury, Clinical Translation Research Award

Issuing agency

Defense Health Agency Contracting Activity - DHACA (Department of Defense)

Opportunity number

HT942526SCIRPCTRA

Funding type

Grant

Funding purpose

Science and Technology and other Research and Development

Status

Open (posted)

Application deadline

Closes November 12, 2026(13 days left)

Published award range

Not published by the agency

Estimated total program funding

$6,120,000

Expected number of awards

3

Cost sharing or match required

No

Eligible applicants (official categories)

• Unrestricted (open to any type of entity, subject to any clarification in Additional Information on Eligibility)

Relevant to

Businesses and NonprofitsHow we determined this: Grants.gov lists eligibility as Unrestricted.

Geographic restrictions

None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.

Assistance Listing (CFDA)

12.420

Official source

View on Grants.gov ↗

Application URL

www.grants.gov/search-results-detail/362225 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.

Source identifier

Grants.gov opportunity ID 362225 · Funding opportunity number HT942526SCIRPCTRA

Posted

May 5, 2026 · Source last updated May 7, 2026

Last verified

October 29, 2026 (against Grants.gov)

Data completeness

83% of key fields published by the sourceNot published: published funding range, eligibility criteria text.

Record confidence

highVerified against the official source; key fields present; no open issues.

Description (from the official listing)

Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Clinical Translation Research Award (CTRA) supports high-impact, new, or emerging clinical research that requires additional preliminary studies, such as feasibility, pilot, or optimization, to prepare for future larger-scale clinical trials or implementation. Primary objectives of this mechanism include:• Accelerating the translation of current and emerging techniques or interventions into clinical use by addressing specific barrier(s) to clinical success for the purpose of de-risking or informing the design of definitive trials.• Identifying the most effective diagnosis, treatment and rehabilitation options to support critical decision-making for patients, clinicians, care partners and policymakers.Distinctive Features:• This funding opportunity contains an Early-Career Partnership Option, which allows for two principal investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.• Applications to this funding opportunity must name at least two spinal cord injury (SCI) community partners who will provide advice and consultation throughout the planning and implementation of the research project.

Agency contact

eBRAP Help Desk 301-682-5507 help@eBRAP.org
help@eBRAP.org